BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BCRX BioCryst制药

休市中 05-02 16:00:00 EDT

8.93

+0.22

+2.53%

盘后8.90

-0.03-0.34%

19:28 EDT

最高9.07	最低8.74	成交量442.17万
今开8.86	昨收8.71	日振幅3.79%
总市值18.68亿	流通市值17.44亿	总股本2.09亿
成交额3,931万	换手率2.26%	流通股本1.95亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"BioCryst制药","latestPrice":8.93,"timestamp":1746216000000,"preClose":8.71,"halted":0,"volume":4421715,"hourTrading":{"tag":"盘后","latestPrice":8.9,"preClose":8.93,"latestTime":"19:28 EDT","volume":77859,"amount":695361.01,"timestamp":1746228512901},"delay":0,"floatShares":195303885,"shares":209207928,"eps":-0.430008,"marketStatus":"休市中","change":0.22,"latestTime":"05-02 16:00:00 EDT","open":8.86,"high":9.07,"low":8.74,"amount":39309758.24611501,"amplitude":0.037887,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.430008,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":762670800000,"exchange":"NASDAQ","adjPreClose":8.71,"preHourTrading":{"tag":"盘前","latestPrice":8.89,"preClose":8.71,"latestTime":"09:28 EDT","volume":2894,"amount":24874.754790000003,"timestamp":1746192480050},"postHourTrading":{"tag":"盘后","latestPrice":8.9,"preClose":8.93,"latestTime":"19:28 EDT","volume":77859,"amount":695361.01,"timestamp":1746228512901},"volumeRatio":1.065405,"impliedVol":0.4761,"impliedVolPercentile":0.344},"requestUrl":"/m/hq/s/BCRX/wiki","defaultTab":"wiki","newsList":[{"id":"2532606407","title":"BioCryst制药盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532606407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532606407?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:17","pubTimestamp":1746037048,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时17分，BioCryst制药股票出现波动，股价快速拉升5.04%。截至发稿，该股报8.87美元/股，成交量279.981万股，换手率1.34%，振幅6.93%。BioCryst制药股票所在的制药行业中，整体涨幅为0.92%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050102172894e93abd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050102172894e93abd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2529538975","title":"BioCryst制药盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529538975?lang=zh_cn&edition=full","pubTime":"2025-04-23 02:16","pubTimestamp":1745345765,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日02时16分，BioCryst制药股票出现波动，股价急速拉升5.05%。截至发稿，该股报7.91美元/股，成交量237.611万股，换手率1.14%，振幅5.25%。BioCryst制药股票所在的制药行业中，整体涨幅为1.01%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230216059740f8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230216059740f8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2527422455","title":"BioCryst制药盘中异动 大幅拉升5.04%报7.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527422455?lang=zh_cn&edition=full","pubTime":"2025-04-16 04:00","pubTimestamp":1744747247,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日04时00分，BioCryst制药股票出现异动，股价大幅拉升5.04%。截至发稿，该股报7.40美元/股，成交量256.671万股，换手率1.23%，振幅6.18%。BioCryst制药股票所在的制药行业中，整体涨幅为0.08%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041604004794d670dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041604004794d670dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4139","BK4547"],"gpt_icon":0},{"id":"2526615459","title":"BioCryst制药盘中异动 下午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526615459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526615459?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:11","pubTimestamp":1744391491,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时11分，BioCryst制药股票出现异动，股价快速上涨5.07%。截至发稿，该股报6.74美元/股，成交量152.509万股，换手率0.73%，振幅6.40%。BioCryst制药股票所在的制药行业中，整体涨幅为1.49%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412011131aa2c6d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412011131aa2c6d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCRX","BK4547"],"gpt_icon":0},{"id":"2518731582","title":"BioCryst制药盘中异动 早盘快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518731582?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:25","pubTimestamp":1741616747,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时25分，BioCryst制药股票出现波动，股价急速下跌5.01%。截至发稿，该股报7.31美元/股，成交量35.2675万股，换手率0.17%，振幅4.16%。BioCryst制药股票所在的制药行业中，整体跌幅为2.11%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102225479640433b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102225479640433b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2516677559","title":"BioCryst制药盘中异动 早盘快速跳水7.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677559?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098751,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，BioCryst制药股票出现异动，股价快速下跌7.85%。截至发稿，该股报7.87美元/股，成交量23.2054万股，换手率0.11%，振幅4.36%。BioCryst制药股票所在的制药行业中，整体跌幅为0.02%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223231a25f04c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223231a25f04c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4547","BCRX"],"gpt_icon":0},{"id":"2516379074","title":"BioCryst制药2024财年实现净利润-88.88百万美元，同比增加60.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516379074?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758437,"startTime":"0","endTime":"0","summary":"3月1日，BioCryst制药公布财报，公告显示公司2024财年净利润为-88.88百万美元，同比增加60.85%；其中营业收入为4.51亿美元，同比增加36.25%，每股基本收益为-0.43美元。从资产负债表来看，BioCryst制药总负债9.66亿美元，其中短期债务35.45百万美元，资产负债比为0.51，流动比率为2.64。机构评级：截至2025年3月1日，当前有11家机构对BioCryst制药目标价做出预测，其中目标均价为15.91美元，其中最低目标价为8.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000046a25817fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000046a25817fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX"],"gpt_icon":0},{"id":"2514056016","title":"Citizens Capital Markets：重申BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由18.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514056016","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514056016?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:51","pubTimestamp":1740498699,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：重申BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由18.00美元调整至18.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25235148385221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BCRX"],"gpt_icon":0},{"id":"1173855464","title":"异动解读 | BCRX第四季度业绩疲软引发7.17%盘中大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1173855464","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173855464?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:33","pubTimestamp":1740407637,"startTime":"0","endTime":"0","summary":"BCRX(BioCryst制药)公司周一盘中大跌7.17%,引起市场广泛关注。这一波动与公司近期披露的2024年第四季度财报数据存在一定关联。\n\n数据显示,BCRX在该季度实现营收1.315亿美元,同比增长40.83%,超出市场预期。不过,公司每股收益为-0.13美元,低于分析师预期的-0.06美元,同比亦无改善。\n\n尽管营收增速喜人,但由于净利润持续亏损,加之EPS表现不佳,市场对BCRX未来增长前景的预期可能受到一定打击,进而引发投资者资金流出,促使股价承压下跌。值得关注的是,该公司日后的研发投入及新药上市进程也可能是股价波动的主要驱动力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BCRX"],"gpt_icon":0},{"id":"2513727313","title":"BioCryst制药盘中异动 股价大跌7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727313?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:30","pubTimestamp":1740407451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时30分，BioCryst制药股票出现异动，股价快速下跌7.06%。截至发稿，该股报8.56美元/股，成交量14.0755万股，换手率0.07%，振幅1.50%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.00%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223052962e982f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223052962e982f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BCRX"],"gpt_icon":0},{"id":"1192786254","title":"异动解读 | BioCryst制药预计明年盈利 股价盘前大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192786254","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192786254?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:02","pubTimestamp":1740402141,"startTime":"0","endTime":"0","summary":"BioCryst制药公司(BCRX)股价今日盘前大涨5.21%,引发市场关注。据公司最新财报预期,这家生物制药公司将在2025年下半年实现季度正EPS和正现金流,并于2026年全年度取得EPS盈利和正现金流。\n\n消息人士称,BioCryst制药在研发创新药物方面取得重大进展,公司业务发展状况良好。投资者对该公司未来前景看好,纷纷入场买入该股,推动了股价上涨。\n\n这家总部位于美国的公司专注于治疗罕见疾病的创新疗法研发。如果未来几个季度业绩符合预期,将标志着公司进入盈利阶段,对公司长期战略及发展意义重大。市场看好BioCryst制药未来的增长潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BCRX"],"gpt_icon":0},{"id":"1169679995","title":"Biocryst制药公司预计将在2025年下半年实现季度正EPS和正现金流，并在2026年全年度实现EPS盈利和正现金流","url":"https://stock-news.laohu8.com/highlight/detail?id=1169679995","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169679995?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:12","pubTimestamp":1740399120,"startTime":"0","endTime":"0","summary":"Biocryst制药公司预计将在2025年下半年实现季度正EPS和正现金流，并在2026年全年度实现EPS盈利和正现金流。以上内容来自Benzinga Earnings专栏，原文如下：Biocryst Pharmaceuticals Expects To Approach Quarterly Positive EPS And Positive Cash Flow In The Second Half Of 2025, And To Be Profitable On An EPS Basis, With Positive Cash Flow, For Full Year 2026","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"gpt_icon":0},{"id":"2513284617","title":"BioCryst Pharma(BCRX.US)：2024年Q4财报实现营收1.315亿美元，前值为9340.1万美元，预期值为1.3亿美元；每股收益为-0.13美元，前值为-0.28美元，预期值为-0.06美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513284617","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513284617?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:11","pubTimestamp":1740399075,"startTime":"0","endTime":"0","summary":"BioCryst Pharma(BCRX.US)：2024年Q4财报实现营收1.315亿美元，前值为9340.1万美元，预期值为1.3亿美元；每股收益为-0.13美元，前值为-0.28美元，预期值为-0.06美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24201148351285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BCRX"],"gpt_icon":0},{"id":"1164848281","title":"BioCryst Pharma 2024年第四季度调整后每股收益$(0.13)不及预期$(0.06)，销售额$1.3153亿超预期$1.3015亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1164848281","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164848281?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:08","pubTimestamp":1740398929,"startTime":"0","endTime":"0","summary":"BioCryst Pharma 报告季度每股亏损$，未达到分析师普遍预期的$，差距为116.67%。相比去年同期每股亏损$，亏损减少了53.57%。公司报告季度销售额为$1.3153亿，超出分析师普遍预期的$1.3015亿，超过预期1.07%。以上内容来自Benzinga Earnings专栏，原文如下：BioCryst Pharma  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 116.67 percent. This is a 53.57 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $131.53 million which beat the analyst consensus estimate of $130.15 million by 1.07 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioCryst Pharma 2024年第四季度调整后每股收益$(0.13)不及预期$(0.06)，销售额$1.3153亿超预期$1.3015亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"gpt_icon":0},{"id":"2509824352","title":"BioCryst制药盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509824352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509824352?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:32","pubTimestamp":1738765951,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时32分，BioCryst制药股票出现异动，股价急速上涨5.07%。截至发稿，该股报8.50美元/股，成交量15.3124万股，换手率0.07%，振幅3.83%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.80%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223231961908fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223231961908fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BCRX"],"gpt_icon":0},{"id":"2509895469","title":"BioCryst制药盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509895469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509895469?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:09","pubTimestamp":1738685389,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时09分，BioCryst制药股票出现波动，股价急速上涨5.09%。截至发稿，该股报8.01美元/股，成交量37.3771万股，换手率0.18%，振幅5.64%。BioCryst制药股票所在的生物技术行业中，整体涨幅为1.16%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000951a2393bb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000951a2393bb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2506581137","title":"BioCryst制药盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506581137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506581137?lang=zh_cn&edition=full","pubTime":"2025-01-28 03:59","pubTimestamp":1738007983,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日03时59分，BioCryst制药股票出现异动，股价急速上涨5.10%。截至发稿，该股报8.03美元/股，成交量178.441万股，换手率0.86%，振幅6.35%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.69%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035944961268c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128035944961268c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2504131119","title":"BioCryst制药盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504131119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504131119?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:33","pubTimestamp":1737145986,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时33分，BioCryst制药股票出现波动，股价快速上涨5.03%。截至发稿，该股报7.42美元/股，成交量248.27万股，换手率1.20%，振幅6.30%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.30%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118043307a22609bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118043307a22609bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2503357437","title":"BioCryst制药盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503357437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503357437?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:48","pubTimestamp":1736866102,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时48分，BioCryst制药股票出现异动，股价大幅下跌5.04%。截至发稿，该股报7.53美元/股，成交量10.6121万股，换手率0.05%，振幅5.86%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.55%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422482296038349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422482296038349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2503030424","title":"Needham：维持BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503030424","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503030424?lang=zh_cn&edition=full","pubTime":"2025-01-13 21:33","pubTimestamp":1736775196,"startTime":"0","endTime":"0","summary":"Needham：维持BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/13213347401786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BCRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocryst.com","stockEarnings":[{"period":"1week","weight":0.0644},{"period":"1month","weight":0.2019},{"period":"3month","weight":0.1304},{"period":"6month","weight":0.0593},{"period":"1year","weight":0.9933},{"period":"ytd","weight":0.1875}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioCryst Pharmaceuticals, Inc.是一家特拉华州公司，最初成立于1986年。该公司是一家全球性生物技术公司，致力于改善遗传性血管性水肿和罕见病患者的生活。该公司利用结构引导药物设计方面的专业知识，目标是开发一流或一流的口服小分子和注射蛋白疗法，以针对难以治疗的罕见疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.580645,"avgChangeRate":0.031172},{"month":2,"riseRate":0.516129,"avgChangeRate":-0.010813},{"month":3,"riseRate":0.354839,"avgChangeRate":0.014971},{"month":4,"riseRate":0.5625,"avgChangeRate":0.048894},{"month":5,"riseRate":0.5625,"avgChangeRate":0.056519},{"month":6,"riseRate":0.612903,"avgChangeRate":0.033442},{"month":7,"riseRate":0.580645,"avgChangeRate":0.119811},{"month":8,"riseRate":0.580645,"avgChangeRate":0.102213},{"month":9,"riseRate":0.354839,"avgChangeRate":-0.048294},{"month":10,"riseRate":0.516129,"avgChangeRate":-0.047322},{"month":11,"riseRate":0.483871,"avgChangeRate":0.039401},{"month":12,"riseRate":0.483871,"avgChangeRate":0.002064}],"exchange":"NASDAQ","name":"BioCryst制药","nameEN":"Biocryst Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCryst制药,BCRX,BioCryst制药股票,BioCryst制药股票老虎,BioCryst制药股票老虎国际,BioCryst制药行情,BioCryst制药股票行情,BioCryst制药股价,BioCryst制药股市,BioCryst制药股票价格,BioCryst制药股票交易,BioCryst制药股票购买,BioCryst制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}